beta

TPIV

TapImmune Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

TapImmune Inc is an immuno-oncology company. The company specializes in the development of peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer.

Market Cap: 40.8 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.tapimmune.com

Shares Outstanding: 10.6 Million

Float: 5.52 Million

Dividend: 0.0 (0.0%)

Beta: -0.961025

Sector: Healthcare

Industry: Biotechnology

Ethical Flags

Longest drawdown: 1144 trading days

From: 2014-03-25 To: 2018-10-17

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2016-09-16 12.0 1.0 12.0
Data provided by IEX Cloud